Left Atrial Appendage (LAA) Occluders

LAA occluder, Watchman

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote that the benefits of the Watchman ...

Lariat Procedure Reduces Stroke Risk in Patients Who Cannot Tolerate Blood Thinn

Shore University Medical Center is one of only a handful of hospitals in the country offering the recent U.S. Food and Drug Administration (FDA)-approved Lariat Suture Delivery Device procedure. Electrophysiologists and interventional cardiologist...

July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip left atrial appendage (LAA) exclusion system devices worldwide.
atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
The TigerPaw System II is a mechanical occlusion device developed by LAAx Inc. When implanted, TigerPaw II safely and effectively occludes
The Simbionix Angio Mentor is a virtual reality-training simulator, providing hands-on practice in a simulated environment for endovascular...
A device for excluding the left atrial appendage has received clearance from the FDA. AtriCure, Inc. has received clearance from the U.S....

Articles

atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
LAA occluder, Watchman
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will...

Video Center

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
2 weeks 14 hours ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
2 weeks 6 days ago
The key cardiology news coming out of the 2014 meeting for the Society of Nuclear Medicine and...
4 weeks 6 days ago
CVIS, cardiovascular information system, webinar
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle efficiency benefits of a modern cardiovascular...
The webinar "Implementing Robotic PCI — Why and How to Start a Successful Program" defines optimal strategies for launching a successful robotic percutaneous coronary intervention (PCI) program. The...
This webinar focuses on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It offers an...